|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2003-7-9
|
|
pubmed:abstractText |
Orthotopic liver transplantation is currently the only curative therapy for chronic end-stage liver disease and acute liver failure. However, a scarcity of cadaveric donors has led to a critical shortage of organs available for transplant. This is further complicated by the prevalence of steatosis in about 13%-50% of donor livers, which is associated with a high risk of dysfunction and primary nonfunction.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Bcl2l1 protein, rat,
http://linkedlifedata.com/resource/pubmed/chemical/Central Nervous System Depressants,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Ethanol,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/STAT3 Transcription Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Stat3 protein, rat,
http://linkedlifedata.com/resource/pubmed/chemical/Trans-Activators,
http://linkedlifedata.com/resource/pubmed/chemical/bcl-X Protein
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0016-5085
|
|
pubmed:author |
pubmed-author:BatkaiSandorS,
pubmed-author:DiehlAnna MaeAM,
pubmed-author:El-AssalOsamaO,
pubmed-author:HongFengF,
pubmed-author:HoshinoSumitoS,
pubmed-author:JarugaBarbaraB,
pubmed-author:KleinAndrew SAS,
pubmed-author:KunosGeorgeG,
pubmed-author:LeeS KSK,
pubmed-author:PanHong-NaHN,
pubmed-author:RadaevaSvetlanaS,
pubmed-author:SunZhaoliZ,
pubmed-author:TianZhigangZ
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
125
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
202-15
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12851884-Animals,
pubmed-meshheading:12851884-Central Nervous System Depressants,
pubmed-meshheading:12851884-Combined Modality Therapy,
pubmed-meshheading:12851884-DNA-Binding Proteins,
pubmed-meshheading:12851884-Disease Models, Animal,
pubmed-meshheading:12851884-Endothelium,
pubmed-meshheading:12851884-Ethanol,
pubmed-meshheading:12851884-Fatty Liver, Alcoholic,
pubmed-meshheading:12851884-Graft Survival,
pubmed-meshheading:12851884-Interleukin-6,
pubmed-meshheading:12851884-Liver,
pubmed-meshheading:12851884-Liver Circulation,
pubmed-meshheading:12851884-Liver Failure,
pubmed-meshheading:12851884-Liver Transplantation,
pubmed-meshheading:12851884-Microcirculation,
pubmed-meshheading:12851884-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:12851884-Rats,
pubmed-meshheading:12851884-Rats, Zucker,
pubmed-meshheading:12851884-STAT3 Transcription Factor,
pubmed-meshheading:12851884-Survival Rate,
pubmed-meshheading:12851884-Trans-Activators,
pubmed-meshheading:12851884-bcl-X Protein
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats.
|
|
pubmed:affiliation |
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Zlsun@jhmi.edu
|
|
pubmed:publicationType |
Journal Article,
In Vitro
|
